The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.
about
The streptococcal collagen-like protein-1 (Scl1) is a significant determinant for biofilm formation by group a StreptococcusNew Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including BiofilmsAntibiotic lock therapy: review of technique and logistical challengesBiofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.In situ ATR-IR spectroscopic and electron microscopic analyses of settlement secretions of Undaria pinnatifida kelp spores.Multimodality imaging of the effects of a novel dentifrice on oral biofilm.[Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?].New materials and devices for preventing catheter-related infections.Effects of a Novel Dental Gel on Plaque and Gingivitis: A Comparative StudyChelator-based catheter lock solutions in eradicating organisms in biofilmThe Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.Prevention of central venous catheter-related infection: update.Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.Design of clinically useful macromolecular iron chelators.Mini-review: Antimicrobial central venous catheters--recent advances and strategies.Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns.Antibiotic-lock therapy: a clinical viewpoint.Biophysics of biofilm infection.A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients.Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms.Antibacterial activity of jalapeño pepper (Capsicum annuum var. annuum) extract fractions against select foodborne pathogens.The Efficacy of Tetrasodium EDTA on Biofilms.Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia.Effects of chelating agent and environmental stresses on microbial biofilms: relevance to clinical microbiology.Loss of antimicrobial effect of trisodium citrate due to 'lock' spillage from haemodialysis catheters.
P2860
Q23913487-B07D12F4-1B70-41EF-A387-7224AE5683E0Q26741342-81AA7EC0-A5E5-4CCA-8A7E-2734CBD253A4Q28082777-A6292C6A-2A6D-4130-AF2E-D6C9427F37A8Q30403958-9B349277-6092-427D-9FA6-06FDB11B4159Q30424697-F15B02FD-8D5B-442B-AC79-58E9F9DB8E65Q30498031-31C63E5C-4949-4BBB-81B3-56E7E55E3774Q34076087-211CCBC9-1C9C-4653-9476-49C172C64861Q34393088-D75E6EFE-A17B-446F-B4CF-CAAD5A3062B1Q35207061-117873A2-AE69-4B3A-B2D6-9BFDAAD175CCQ35655949-2487A8B9-D5FD-431B-9E90-CDE9EA002086Q36505410-AEF4990A-F876-4DE2-BDFA-84EC33BB16E7Q36683547-B8CED86F-F6EE-4579-A2C7-7F8FD7EDF1DDQ36933039-79CD01B1-70C9-479D-92E3-1EB9BF0DE5D0Q37341004-24FFE79D-7756-4041-BB45-51D524901A36Q37706983-3460E086-E914-4F14-8FFC-200DE5551F23Q37802887-5B24C6D3-567A-4CDA-A9E9-CFCA2513D326Q37860818-5E64E6EC-A063-4F73-8510-77CA67B59B86Q37884088-3A4F9C4A-1E60-4947-ABBE-61DEFC33B78CQ37896090-E16C9A5A-AE0A-4760-A5EF-8FC4AD79C850Q38020228-09CB96EE-053F-4537-992B-C96EF03927ADQ38168929-AB6DFCDE-B7BD-4538-85F3-85885C4E4776Q38174582-1EEC8D46-941A-4493-B302-44203257A305Q38377967-5617CE75-A9CF-47FC-93C2-A223C551BDA0Q41182648-C7B7447E-C0C7-436A-8FA6-CF2F2ADE36E5Q41466021-476A7B99-339E-4388-82E9-B78034D8F336Q42128626-EC841F7D-A994-454B-88A8-AB79B359FB11Q42239218-91827A5D-76B9-49D4-BC2F-281D71EC05A3Q49564195-E909FC81-E101-498B-BA13-ED3C211BBA42Q49679823-27443A55-A537-46D5-8F86-B32955F42AE6Q52608269-1926339D-52C6-41F3-A005-AAC1FB17F009Q53622479-7D803A46-4767-442F-9581-658E435048FB
P2860
The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of chelators in preve ...... elated bloodstream infections.
@en
The role of chelators in preve ...... elated bloodstream infections.
@nl
type
label
The role of chelators in preve ...... elated bloodstream infections.
@en
The role of chelators in preve ...... elated bloodstream infections.
@nl
prefLabel
The role of chelators in preve ...... elated bloodstream infections.
@en
The role of chelators in preve ...... elated bloodstream infections.
@nl
P2093
P1476
The role of chelators in preve ...... elated bloodstream infections.
@en
P2093
Issam I Raad
Ray Hachem
Robert Sherertz
Xavier M Keutgen
Xiang Fang
Ying Jiang
P304
P356
10.1097/QCO.0B013E32830634D8
P577
2008-08-01T00:00:00Z